151 reports of this reaction
1.6% of all CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL reports
#19 most reported adverse reaction
NASOPHARYNGITIS is the #19 most commonly reported adverse reaction for CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL, manufactured by CareFusion 213 LLC. There are 151 FDA adverse event reports linking CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL to NASOPHARYNGITIS. This represents approximately 1.6% of all 9,167 adverse event reports for this drug.
Patients taking CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL who experience nasopharyngitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NASOPHARYNGITIS is a less commonly reported adverse event for CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL, but still significant enough to appear in the safety profile.
In addition to nasopharyngitis, the following adverse reactions have been reported for CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL:
The following drugs have also been linked to nasopharyngitis in FDA adverse event reports:
NASOPHARYNGITIS has been reported as an adverse event in 151 FDA reports for CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
NASOPHARYNGITIS accounts for approximately 1.6% of all adverse event reports for CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL, making it a notable side effect.
If you experience nasopharyngitis while taking CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.